Order Article Reprints

Job S, de Reyniès A, Heller B, Weiss A, Guérin E, Macabre C, Ledrappier S, Bour C, Wasylyk C, Etienne-Selloum N, et al. Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on EREG-Driven Oncogenic Addiction. Cancers. 2019; 11(6):795. https://doi.org/10.3390/cancers11060795

Job, Sylvie, Aurélien de Reyniès, Betty Heller, Amélie Weiss, Eric Guérin, Christine Macabre, Sonia Ledrappier, Cyril Bour, Christine Wasylyk, Nelly Etienne-Selloum, and et al. 2019. "Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on EREG-Driven Oncogenic Addiction" Cancers 11, no. 6: 795. https://doi.org/10.3390/cancers11060795

Job, S., de Reyniès, A., Heller, B., Weiss, A., Guérin, E., Macabre, C., Ledrappier, S., Bour, C., Wasylyk, C., Etienne-Selloum, N., Brino, L., Gaiddon, C., Wasylyk, B., & Jung, A. C. (2019). Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on EREG-Driven Oncogenic Addiction. Cancers, 11(6), 795. https://doi.org/10.3390/cancers11060795